Skip to main content
MANE
NYSE Life Sciences

Veradermics Q2 Loss Widens to $23.5M, Cash Runway Extended to 2030

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$110
Mkt Cap
$4.627B
52W Low
$32
52W High
$131.24
52W Position info
244% above low
Off High info
16% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

MANE has more than doubled off its 52-week low of $32.

Summary

Veradermics reported a Q2 net loss of $23.5 million, wider than the prior year, driven by higher R&D and G&A expenses tied to VDPHL01 clinical development and commercial readiness. The company ended the quarter with $819.9 million in cash, which it expects to fund operations into 2030, including a potential VDPHL01 launch. This follows the July Phase 2 success in female pattern hair loss and an S-1 filing last week to register 16.8 million shares for resale. Topline Phase 3 data in men is expected in the second half of 2026, a key catalyst for the stock.

At the time of this announcement, MANE was trading at $110.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $32.00 to $131.24. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MANE - Latest Insights

MANE
Nov 13, 2026, 5:39 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $129.66
Real-time Price: $125.10 info
Change: -$4.56 (-4%) info
Market Cap: $5.289B info
MANE
Nov 10, 2026, 4:57 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $148.44
Real-time Price: $125.10 info
Change: -$23.34 (-16%) info
Market Cap: $5.289B info
MANE
Nov 10, 2026, 8:54 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $142.72
Real-time Price: $125.10 info
Change: -$17.62 (-12%) info
Market Cap: $5.289B info
MANE
Nov 09, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $142.00
Real-time Price: $125.10 info
Change: -$16.90 (-12%) info
Market Cap: $5.289B info
MANE
Nov 08, 2026, 6:00 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $139.33
Real-time Price: $125.10 info
Change: -$14.23 (-10%) info
Market Cap: $5.289B info